SPINIFEX PHARMACEUTICALS

spinifex-pharmaceuticals-logo

Spinifex is backed by a syndicate of experienced life science investors including Novo Ventures, Canaan Partners, GBS Venture Partners, Brandon Capital Partners, Uniseed and UniQuest. Founded in 2005, Spinifex raised an initial AU$3.25 million in Series A fundraising and a total of AU$23.08 in Series B funding support the further development of EMA401. Spinifex raised a US$45 million in a Series C round led by Novo Ventures and including additional new investor Canaan Partners in 2014. Spinif... ex has a strong portfolio of intellectual property around its lead compound EMA01, follow on candidates and the use of AT2 receptor antagonists to treat both neuropathic & inflammatory pain and restore nerve conduction velocity deficits, including granted US, European, Japanese, Chinese, Australian and New Zealand patents.

#People #Financial #Website #More

SPINIFEX PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2005-06-01

Address:
Preston, Lancashire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.spinifexpharma.com.au

Total Employee:
11+

Status:
Closed

Contact:
+61399381205

Email Addresses:
[email protected]

Total Funding:
66.46 M USD

Technology used in webpage:
Viewport Meta SPF Domain Not Resolving AJAX Libraries API PHP Symantec.cloud Akamai DNS Fluccs



Current Advisors List

andrew-rice_image

Andrew Rice Scientific Advisor @ Spinifex Pharmaceuticals
Advisor

not_available_image

Thomas Schnitzer Scientific Advisor @ Spinifex Pharmaceuticals
Advisor

chas-bountra_image

Chas Bountra Chair @ Spinifex Pharmaceuticals
Board_member

praveen-anand_image

Praveen Anand Scientific Advisor @ Spinifex Pharmaceuticals
Advisor

robert-dworkin_image

Robert Dworkin Scientific Advisor @ Spinifex Pharmaceuticals
Advisor

chris-nave_image

Chris Nave Board of Directors @ Spinifex Pharmaceuticals
Board_member

heath-lukatch_image

Heath Lukatch Chairman of the Board @ Spinifex Pharmaceuticals
Board_member

declan-doogan_image

Declan Doogan Scientific Advisor @ Spinifex Pharmaceuticals
Advisor

Current Employees Featured

andrew-baker_image

Andrew Baker
Andrew Baker Team Member @ Spinifex Pharmaceuticals
Team Member

not_available_image

Fred Reno
Fred Reno VP of Toxicology & Consultant @ Spinifex Pharmaceuticals
VP of Toxicology & Consultant

not_available_image

Colleen Johnson
Colleen Johnson Associate Directorof Toxicology & Consultant @ Spinifex Pharmaceuticals
Associate Directorof Toxicology & Consultant

Founder


tom-mccarthy_image

Tom McCarthy

Investors List

uniseed-pty_image

Uniseed Ventures

Uniseed Ventures investment in Series C - Spinifex Pharmaceuticals

brandon-capital-partners_image

Brandon Capital Partners

Brandon Capital Partners investment in Series C - Spinifex Pharmaceuticals

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series C - Spinifex Pharmaceuticals

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Spinifex Pharmaceuticals

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series C - Spinifex Pharmaceuticals

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series B - Spinifex Pharmaceuticals

brandon-capital-partners_image

Brandon Capital Partners

Brandon Capital Partners investment in Series B - Spinifex Pharmaceuticals

uniseed-pty_image

Uniseed Ventures

Uniseed Ventures investment in Series B - Spinifex Pharmaceuticals

uniseed-pty_image

Uniseed Ventures

Uniseed Ventures investment in Series A - Spinifex Pharmaceuticals

symbiosis-group_image

Symbiosis Group

Symbiosis Group investment in Series A - Spinifex Pharmaceuticals

Official Site Inspections

http://www.spinifexpharma.com.au

Unable to get host informations!!!

Loading ...

More informations about "Spinifex Pharmaceuticals" on Search Engine